niceritrol has been researched along with Hyperphosphatemia in 1 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Hyperphosphatemia: A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bostom, AG | 1 |
1 other study available for niceritrol and Hyperphosphatemia
| Article | Year |
|---|---|
Binder blinders-niacin of omission?
Topics: Animals; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Humans; Hyperphosphatem | 2010 |